MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202641001545 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Jan. 7, for 'development of a nanoparticle enhanced transdermal patch for insulin delivery.'
Inventor(s) include Dr. Chimbili Saibharath; Dr. Mahendran K.; and Dr. S Rajeshkumar.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a nanoparticle-based transdermal system for controlled insulin delivery. Insulin is encapsulated within biodegradable polymeric nanoparticles to enhance its stability and permeability across the skin barrier. These nanoparticles are integrated into a flexible polymeric patch formulated with film-forming agents and permeation enhancers. The patch allows sustained release of insulin over an extended period, offering a non-invasive and patient-friendly alternative to injections. In vitro and ex vivo evaluations demonstrate improved insulin transport and prolonged therapeutic effect. The invention aims to improve compliance in diabetic patients and can be adapted for transdermal delivery of other peptide-based therapeutics."
Disclaimer: Curated by HT Syndication.
